Pneumology Department, Vall d'Hebron University Hospital/Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Adv Ther. 2023 Oct;40(10):4236-4263. doi: 10.1007/s12325-023-02609-8. Epub 2023 Aug 4.
Discharge bundles, comprising evidence-based practices to be implemented prior to discharge, aim to optimise patient outcomes. They have been recommended to address high readmission rates in patients who have been hospitalised for an exacerbation of chronic obstructive pulmonary disease (COPD). Hospital readmission is associated with increased morbidity and healthcare resource utilisation, contributing substantially to the economic burden of COPD. Previous studies suggest that COPD discharge bundles may result in fewer hospital readmissions, lower risk of mortality and improvement of patient quality of life. However, evidence for their effectiveness is inconsistent, likely owing to variable content and implementation of these bundles. To ensure consistent provision of high-quality care for patients hospitalised with an exacerbation of COPD and reduce readmission rates following discharge, we propose a comprehensive discharge protocol, and provide evidence highlighting the importance of each element of the protocol. We then review care bundles used in COPD and other disease areas to understand how they affect patient outcomes, the barriers to implementing these bundles and what strategies have been used in other disease areas to overcome these barriers. We identified four evidence-based care bundle items for review prior to a patient's discharge from hospital, including (1) smoking cessation and assessment of environmental exposures, (2) treatment optimisation, (3) pulmonary rehabilitation, and (4) continuity of care. Resource constraints, lack of staff engagement and knowledge, and complexity of the COPD population were some of the key barriers inhibiting effective bundle implementation. These barriers can be addressed by applying learnings on successful bundle implementation from other disease areas, such as healthcare practitioner education and audit and feedback. By utilising the relevant implementation strategies, discharge bundles can be more (cost-)effectively delivered to improve patient outcomes, reduce readmission rates and ensure continuity of care for patients who have been discharged from hospital following a COPD exacerbation.
出院套餐包括在出院前实施的基于证据的实践,旨在优化患者的结局。为了解决因慢性阻塞性肺疾病(COPD)加重而住院的患者再入院率高的问题,建议采用这些套餐。医院再入院与发病率增加和医疗资源利用增加有关,这对 COPD 的经济负担有很大影响。先前的研究表明,COPD 出院套餐可能会减少医院再入院次数、降低死亡率和改善患者的生活质量。然而,其有效性的证据不一致,这可能是由于这些套餐的内容和实施方式不同。为了确保为因 COPD 加重而住院的患者提供一致的高质量护理并降低出院后的再入院率,我们提出了一个全面的出院方案,并提供了强调方案每个要素重要性的证据。然后,我们回顾了 COPD 及其他疾病领域中使用的护理套餐,以了解它们如何影响患者结局、实施这些套餐的障碍以及在其他疾病领域中使用了哪些策略来克服这些障碍。我们确定了患者出院前需要审查的四项基于证据的护理套餐项目,包括(1)戒烟和环境暴露评估、(2)治疗优化、(3)肺康复和(4)护理连续性。资源限制、员工参与度和知识缺乏以及 COPD 人群的复杂性是阻碍有效套餐实施的一些关键障碍。可以通过从其他疾病领域(如医疗保健从业者教育和审核反馈)应用成功实施套餐的经验来解决这些障碍。通过利用相关的实施策略,可以更有效地(成本有效地)提供出院套餐,以改善患者结局、降低再入院率并确保 COPD 加重后出院的患者的护理连续性。